https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Thus, all GuNAs (GuNA-T, -A, -G, and -mC) are now available to be examined in therapeutic applications.We describe a divergent and enantioselective total synthesis of (+)-ieodomycin A and (+)-ieodomycin B with three stereoisomers. The main advantage of the present synthesis is the late-stage elaboration of the side chain, which would afford a wide range of structurally diverse analogs with interesting bioactivities.A mild, chemoselective and sustainable biocatalysed synthesis of sulfoxides has been developed exploiting CALB